Gene · 554
Papers2,697
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
261 to 280 of 2,697
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Short-term association between outdoor temperature and the hydration-marker copeptin: a pooled analysis in five cohorts. | EBioMedicine | 2023 | 37556945 | PubTator, text mining | PubMed |
| Incidence trends and risk factors for hyponatremia in epilepsy patients: A large-scale real-world data study. | Heliyon | 2023 | 37554799 | PubTator, text mining | PubMed |
| Vasoplegia: A Review. | Methodist Debakey Cardiovasc J | 2023 | 37547893 | PubTator, text mining | PubMed |
| Shifting perspectives in liver diseases after kidney transplantation. | World J Hepatol | 2023 | 37547033 | PubTator, text mining | PubMed |
| Genotypic variability in patients with clinical diagnosis of Bartter syndrome type 3. | Sci Rep | 2023 | 37537162 | PubTator, text mining | PubMed |
| High C1QTNF1 expression mediated by potential ncRNAs is associated with poor prognosis and tumor immunity in kidney renal clear cell carcinoma. | Front Mol Biosci | 2023 | 37529377 | PubTator, text mining | PubMed |
Dilemma Facing Patients Aged 75 Years and Older on Fluid Restriction When Drug Package Inserts Advise Use of a Lot of Water: A Cross-Sectional, Descriptive, and Hypothesis-Generating Study Using a Large Claims Database. | Drugs Real World Outcomes | 2023 | 37526854 | PubTator, text mining | PubMed |
| Tolvaptan for water retention in heart failure: a systematic review. | Syst Rev | 2023 | 37516894 | PubTator, text mining | PubMed |
| PKD1 Mutation Is a Biomarker for Autosomal Dominant Polycystic Kidney Disease. | Biomolecules | 2023 | 37509056 | PubTator, text mining | PubMed |
| Long-term low-dose tolvaptan efficacy and safety in SIADH. | Endocrine | 2023 | 37507553 | PubTator, text mining | PubMed |
| Challenges for Circular Economy under the EU 2020/741 Wastewater Reuse Regulation. | Glob Chall | 2023 | 37483424 | PubTator, text mining | PubMed |
| Intrarenal Mechanisms of Sodium-Glucose Cotransporter-2 Inhibitors on Tubuloglomerular Feedback and Natriuresis. | Endocrinol Metab (Seoul) | 2023 | 37482684 | PubTator, text mining | PubMed |
| Single hormone or synthetic agonist induces Gs/Gi coupling selectivity of EP receptors via distinct binding modes and propagating paths. | Proc Natl Acad Sci U S A | 2023 | 37478163 | PubTator, text mining | PubMed |
| Role of insulin-like growth factor 1 (IGF1) in the regulation of mitochondrial bioenergetics in zebrafish oocytes: lessons from in vivo and in vitro investigations. | Front Cell Dev Biol | 2023 | 37457295 | PubTator, text mining | PubMed |
| [Clinical and laboratory characteristics of arginine vasopressin resistance, caused by a new homozygous mutation p.R113C in AQP2]. | Probl Endokrinol (Mosk) | 2023 | 37448274 | PubTator, text mining | PubMed |
| Ectopic ACTH Cushing's syndrome caused by a large-cell neuroendocrine lung carcinoma responding to desmopressin. | Endocr Oncol | 2023 | 37434650 | PubTator, text mining | PubMed |
| Profiling of basal and ligand-dependent GPCR activities by means of a polyvalent cell-based high-throughput platform. | Nat Commun | 2023 | 37407564 | PubTator, text mining | PubMed |
| GPCR targeting of E3 ubiquitin ligase MDM2 by inactive β-arrestin. | Proc Natl Acad Sci U S A | 2023 | 37399373 | PubTator, text mining | PubMed |
| Efficacy evaluation of chimeric antigen receptor-modified human peritoneal macrophages in the treatment of gastric cancer. | Br J Cancer | 2023 | 37386139 | PubTator, text mining | PubMed |
| Medical Management of Pulmonary Arterial Hypertension: Current Approaches and Investigational Drugs. | Pharmaceutics | 2023 | 37376028 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/554/papers?page=14